Rigel Pharmaceuticals Inc (RIGL)

Total Costs & Expenses

$189.74M

TTM · Period ending: · USD

RIGL logo

RIGL Total Costs & Expenses

Latest reported$189.74M
RIGL TTM Total Costs & Expenses ($38.72M → $189.74M)
High-resolution chart · PNG

RIGL total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
189,735,000
175,189,000
168,816,000
163,125,000
163,334,000
159,146,000
155,086,000
147,971,000
139,319,000
135,078,000
137,373,000
152,746,000
160,960,000
171,591,000
175,792,000
168,420,000
168,935,000
165,465,000
161,732,000
157,182,000
148,024,000
142,123,000
137,594,000
133,054,000
133,778,000
132,111,000
128,379,000
130,967,000
127,308,000
123,460,000
117,192,000
108,082,000
97,602,000
89,048,000
84,100,000
76,672,000
78,646,000
81,544,000
84,354,000
86,851,000
85,899,000
82,815,000
80,638,000
89,972,000
91,235,000
97,533,000
99,499,000
91,575,000
92,786,000
91,615,000
94,940,000
97,862,000
101,180,000
103,277,000
101,627,000
101,921,000
98,748,000
94,318,000
91,118,000
84,877,000
84,405,000
84,932,000
89,683,000
95,866,000
100,597,000
108,116,000
112,787,000
120,945,000
132,972,000
138,251,000
136,714,000
130,961,000
112,705,000
58,778,000
50,915,000
42,680,000
41,108,000
77,688,000
76,520,000
72,604,000
70,809,000
70,115,000
64,448,000
64,344,000
64,262,000
61,040,000
61,600,000
59,576,000
55,749,000
54,445,000
51,882,000
49,592,000
50,196,000
52,313,000
52,804,000
52,099,000
48,967,000
44,860,000
40,263,000
68,003,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.